Mini-monoka stenting for patients with perennial allergic conjunctivitis

ABSTRACT

Purpose: To assess the effectiveness of mini-monoka (MM) stenting in treating patients with perennial allergic conjunctivitis (PAC) and punctal stenosis.

Methods: A retrospective case analysis was performed on 20 patients (40 eyes) who suffered from PAC with punctal stenosis who underwent MM (FCI Ophthalmics, Pembroke, MA, USA) stenting.

Results: Nineteen patients (95%) were females, with an age range of 19–66 years (average 40.6 ± 25.4 years). All 20 patients (100% of eyes) had signs of PAC and punctal stenosis. All 20 patients (40 eyes) had received previous topical treatment including steroids. Nineteen patients (95% of eyes) had significant improvement in their allergy symptoms (tearing and conjunctival inflammation) following MM stenting.

Conclusions: Stenosis of the punctum may play a role in the relapsing symptoms in PAC. MM stenting is a simple, safe, effective, and relatively non-invasive treatment option for the management of PAC in the presence of punctal stenosis.

KEYWORDS:

• Mini-monoka stenting
• allergic conjunctivitis
• chronic allergic conjunctivitis
• perennial allergic conjunctivitis
• punctal stenosis

Disclosure statement

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the article.